Phase II pivotal trial of valproic acid [Savicol] for the treatment of colorectal polyps in patients with familial adenomatous polyposis

Trial Profile

Phase II pivotal trial of valproic acid [Savicol] for the treatment of colorectal polyps in patients with familial adenomatous polyposis

Recruiting
Phase of Trial: Phase II

Latest Information Update: 19 Aug 2008

At a glance

  • Drugs Valproic acid (Primary)
  • Indications Colorectal cancer; Familial adenomatous polyposis
  • Focus Adverse reactions; Biomarker; Registrational; Therapeutic Use
  • Sponsors TopoTarget
  • Most Recent Events

    • 02 Apr 2008 Results are expected in 2008.
    • 27 Dec 2007 Status change
    • 19 Dec 2007 46 patients have been enrolled and 26 patients have completed 6 months treatment. In addition, 13 patients have completed 6 months treatment in the extension phase.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top